Stay updated with breaking news from Benjamin Lightburn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...
VANCOUVER, BC, April 2, 2024 /CNW/ - Filament Health Corp. , a clinical-stage natural psychedelic drug development company, released its fourth quarter financial results and operational highlights...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced the appointment of Michael Messinger, CPA, to its Board of Directors (the "Board"). Mr. Messinger will also serve as the Chair of the Company's Audit Committee.
VANCOUVER, BC, Dec. 18, 2023 /CNW/ - Filament Health Corp. , a clinical‐stage natural psychedelic drug development company, today announced that the special meeting of its securityholders held...
VANCOUVER, BC, Nov. 23, 2023 /CNW/ - Filament Health Corp. , a clinical–stage natural psychedelic drug development company, today announced that the Company has signed a non-binding term sheet ...